MS campaign to support people living with multiple sclerosis
It’s estimated that 130,000 people across the UK have multiple sclerosis (MS) – a condition which causes damage to the nerves in the brain and spinal cord – with 100 people diagnosed every week.
While the COVID-19 pandemic has challenged us all, people living with MS have experienced additional pressures that have affected their health and the way they interact with their health services.
A recent survey of 1,840 people living with MS, initiated and funded by Novartis Pharmaceuticals UK Ltd and developed in partnership with the Multiple Sclerosis Trust (MS Trust), found that:
- One in three hadn’t had a consultation with a neurologist for more than a year (it is recommended to see a neurologist and MS nurse at least once a year).
- Nearly half said their access to relevant care and support was affected in some way during the pandemic.
- Nearly one in five said they experienced disruption to appointment.
Aston spoke to David Martin, CEO at MS Trust and MS patient Phoebe Day.
Ads help us keep this site online